These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 25862138)

  • 1. Can the previous therapeutic control of the main risk factors of cerebrovascular disease influence the acetylsalicylic Acid-nonresponsive status in acute ischemic stroke patients? Results from a portuguese prospective cohort study.
    Freitas-Silva M; Gonçalves L; Medeiros R; Nunes JP
    J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1383-9. PubMed ID: 25862138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma triglycerides as predictors of platelet responsiveness to aspirin in patients after first ischemic stroke.
    Karepov V; Tolpina G; Kuliczkowski W; Serebruany V
    Cerebrovasc Dis; 2008; 26(3):272-6. PubMed ID: 18648200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin and Aspirin Pretreatment Are Associated with Lower Neurological Deterioration and Platelet Activity in Patients with Acute Ischemic Stroke.
    Yi X; Han Z; Wang C; Zhou Q; Lin J
    J Stroke Cerebrovasc Dis; 2017 Feb; 26(2):352-359. PubMed ID: 27793535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variable platelet response to aspirin in patients with ischemic stroke.
    Hohlfeld T; Weber AA; Junghans U; Schumacher M; Boucher M; Schrör K; Siebler M
    Cerebrovasc Dis; 2007; 24(1):43-50. PubMed ID: 17519543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythrocyte promotion of platelet reactivity decreases the effectiveness of aspirin as an antithrombotic therapeutic modality: the effect of low-dose aspirin is less than optimal in patients with vascular disease due to prothrombotic effects of erythrocytes on platelet reactivity.
    Valles J; Santos MT; Aznar J; Osa A; Lago A; Cosin J; Sanchez E; Broekman MJ; Marcus AJ
    Circulation; 1998 Feb; 97(4):350-5. PubMed ID: 9468208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100(®) and VerifyNow(®).
    Kinsella JA; Tobin WO; Cox D; Coughlan T; Collins R; O'Neill D; Murphy RP; McCabe DJ
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e84-92. PubMed ID: 22981273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin responsiveness in acute brain ischaemia: association with stroke severity and clinical outcome.
    Schwammenthal Y; Tsabari R; Shenkman B; Schwartz R; Matetzky S; Lubetsky A; Orion D; Israeli-Korn S; Chapman J; Savion N; Varon D; Tanne D
    Cerebrovasc Dis; 2008; 25(4):355-61. PubMed ID: 18305387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenously administered acetylsalicylic acid in combination with low-dose heparin in acute ischemic stroke: a safety analysis.
    Büttner T; Hellwig K; Müller T; Kuhn W
    Clin Neuropharmacol; 1998; 21(1):48-51. PubMed ID: 9579285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to acetylsalicylic acid in patients after ischemic stroke.
    Zytkiewicz M; Giełwanowska L; Wojtasińska E; Psuja P; Zawilska K
    Pol Arch Med Wewn; 2008 Dec; 118(12):727-33. PubMed ID: 19202951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiplatelet effect of aspirin in patients with cerebrovascular disease.
    Alberts MJ; Bergman DL; Molner E; Jovanovic BD; Ushiwata I; Teruya J
    Stroke; 2004 Jan; 35(1):175-8. PubMed ID: 14671242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADP-induced platelet aggregation in acute ischemic stroke patients on aspirin therapy.
    Cha JK; Jeon HW; Kang MJ
    Eur J Neurol; 2008 Dec; 15(12):1304-8. PubMed ID: 19049546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of aspirin response measured by urinary 11-dehydrothromboxane B2 and VerifyNow aspirin assay in patients with ischemic stroke.
    Dharmasaroja PA; Sae-Lim S
    J Stroke Cerebrovasc Dis; 2014; 23(5):953-7. PubMed ID: 24126290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment with aspirin and etiology of first-ever ischemic stroke in young and middle-aged patients.
    Telman G; Kouperberg E; Sprecher E; Yarnitsky D
    J Neurol Sci; 2009 Jun; 281(1-2):2-5. PubMed ID: 19351569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale, design and baseline data of a randomized, double-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASA with clopidogrel) and telmisartan versus placebo in patients with strokes: the Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS).
    Diener HC; Sacco R; Yusuf S; ;
    Cerebrovasc Dis; 2007; 23(5-6):368-80. PubMed ID: 17337887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial fibrillation patients do not benefit from acetylsalicylic acid.
    Själander S; Själander A; Svensson PJ; Friberg L
    Europace; 2014 May; 16(5):631-8. PubMed ID: 24158253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prior antiplatelet use and infarct volume in ischemic stroke.
    Ovbiagele B; Buck BH; Liebeskind DS; Starkman S; Bang OY; Ali LK; Villablanca JP; Salamon N; Yun SW; Pineda S; Saver JL
    J Neurol Sci; 2008 Jan; 264(1-2):140-4. PubMed ID: 17854835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin use prior to ischemic stroke onset is associated with decreased in-hospital mortality.
    Hassan Y; Al-Jabi SW; Aziz NA; Looi I; Zyoud SH
    Fundam Clin Pharmacol; 2011 Jun; 25(3):388-94. PubMed ID: 20608996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Low doses of acetylsalicylic acid effectively inhibits thrombocyte aggregation after ischemic stroke].
    Oláh L; Misz M; Bereczki D; Fekete I; Bordánné JE; Takács EI
    Orv Hetil; 1996 Mar; 137(9):455-9. PubMed ID: 8714038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards a rationale of platelet aggregation monitoring in stroke prophylaxis?
    von Lewinski F; Riggert J; Paulus W
    J Stroke Cerebrovasc Dis; 2009; 18(2):111-5. PubMed ID: 19251186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of persistence with antiplatelet therapy on recurrent ischemic stroke and predictors of nonpersistence among ischemic stroke survivors.
    Burke JP; Sander S; Shah H; Zarotsky V; Henk H
    Curr Med Res Opin; 2010 May; 26(5):1023-30. PubMed ID: 20199138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.